CNS Pharmaceuticals logo
CNS Pharmaceuticals CNSP
$ 0.11 -1.73%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

CNS Pharmaceuticals Cash Flow 2011-2024 | CNSP

Annual Cash Flow CNS Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Operating Cash Flow

-14.1 M -10.6 M -13.5 M -7.32 M -3.55 M -716 K - - - - - - -

Depreciation & Amortization

4.13 K 11.8 K 13.1 K 11.1 K 1.96 K - - - - - - - -

Accounts Payables

- - 1.98 M 946 K 244 K - - - - - - - -

Accounts Receivables

- - - - - - - - - - - - -

Total Inventories

- - - - - - - - - - - - -

All numbers in USD currency

Quarterly Cash Flow CNS Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Operating Cash Flow

- - -3.19 M - - - -4.82 M - -8.25 M -6.44 M -3.08 M - -10.3 M -8.31 M -3.31 M - -5.87 M -4.6 M -1.86 M - -1.08 M -700 K -82.7 K - -557 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Depreciation & Amortization

- - 818 - - - 1.28 K - 9.38 K 6.58 K 3.38 K - 9.58 K 6.21 K 3 K - 7.95 K 4.79 K 1.92 K - 865 167 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Accounts Payables

- - - - - 3.57 M 2.78 M 3.68 M 1.01 M 491 K 490 K 1.52 M 1.46 M 892 K 1.06 M 946 K 946 K 946 K 946 K 244 K 244 K 244 K 244 K 128 K 128 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Accounts Receivables

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Inventories

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency